806.5500 11.00 (1.38%)
NSE Oct 01, 2025 15:31 PM
Volume: 370.0K
 

806.55
1.38%
HDFC Securities
Natco Pharma Ltd Q3FY18 results comment Revenue grew by 31.76% to Rs. 562.2 Cr in Q3FY18 when compared to the previous quarter. On the other hand, it decreased by 16.08% when compared with Q3FY17.
Natco Pharma Ltd. is trading below all available SMAs
More from Natco Pharma Ltd.
All earning calls
Investor presentations from Natco Pharma Ltd.
All investor presentations